SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
REVENUE	$ 2,377,205	$ 3,028,945
COST OF REVENUE	(2,008,308)	(2,672,612)
GROSS PROFIT	368,897	356,333
OTHER INCOME	117,344	46,394
General and administrative	(536,872)	(368,036)
(LOSS)/PROFIT FROM OPERATIONS	(50,631)	34,691
FINANCE COSTS	(2,445)	(3,326)
(LOSS)/PROFIT BEFORE TAX	(53,076)	31,365
Tax expense	(15,990)	(14,299)
Net (loss)/profit	(69,066)	17,066
FINANCE COSTS	2,445	3,326
BioNexus Malaysia [Member]
REVENUE	7,436	24,269
COST OF REVENUE	(5,347)	(8,038)
GROSS PROFIT	2,089	16,231
OTHER INCOME	1,126	2,076
General and administrative	(46,255)	(44,042)
(LOSS)/PROFIT FROM OPERATIONS	(43,040)	(25,735)
FINANCE COSTS	(666)	(799)
(LOSS)/PROFIT BEFORE TAX	(43,706)	(52,269)
Tax expense	0	0
Net (loss)/profit	(43,706)	(52,269)
FINANCE COSTS	666	799
Chemrex [Member]
REVENUE	2,369,769	3,004,676
COST OF REVENUE	(2,002,961)	(2,664,574)
GROSS PROFIT	366,808	340,102
OTHER INCOME	116,218	44,306
General and administrative	(383,177)	(297,769)
(LOSS)/PROFIT FROM OPERATIONS	99,849	86,639
FINANCE COSTS	(1,779)	(2,527)
(LOSS)/PROFIT BEFORE TAX	98,070	170,751
Tax expense	(15,990)	(14,299)
Net (loss)/profit	82,080	502,730
FINANCE COSTS	1,779	2,527
BGLC [Member]
REVENUE	0	0
COST OF REVENUE	0	0
GROSS PROFIT	0	0
OTHER INCOME	0	12
General and administrative	(107,440)	(26,225)
(LOSS)/PROFIT FROM OPERATIONS	(107,440)	(26,213)
FINANCE COSTS	0	0
(LOSS)/PROFIT BEFORE TAX	(107,440)	(52,426)
Tax expense	0	0
Net (loss)/profit	(107,440)	(52,426)
FINANCE COSTS	$ 0	$ 0